The TRPV1 channel has become a potentially relevant target for metabolic intervention, including insulin resistance, obesity, type 2 diabetes, and nonalcoholic fatty liver, due to its presence in a variety of metabolic tissues. The gene discussed is TRPV1; the disease is Obesity.